Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes model
- PMID: 35533022
- PMCID: PMC9434566
- DOI: 10.1111/jdi.13829
Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes model
Abstract
Aims/introduction: Some women develop type 1 diabetes during pregnancy or immediately after delivery. However, the underlying pathophysiology remains largely unknown, probably because of the lack of a suitable animal model. In this study, we administered pregnant NOD mice with an anti-CD25 antibody to reduce regulatory T cells along with poly I:C and examined the onset of diabetes.
Materials and methods: Anti-CD25 antibody and poly I:C were intraperitoneally administered to mated female NOD mice. Mice delivered within 3 weeks after the treatment, and the onset of diabetes during pregnancy or within 6 weeks after delivery was examined. Some mice were killed 1 week after treatment, and their spleen and pancreas were excised to examine the expression levels of cytokines and for histological examination.
Results: Half of the mice treated with anti-CD25 antibody plus poly I:C developed diabetes, as compared with none of the poly I:C-injected mice (P < 0.05). The ratios of interleukin-18/forkhead box P3 and granzyme B/forkhead box P3 were higher in the pancreas of anti-CD25 antibody plus poly I:C-treated mice than in the pancreas of control mice. The insulitis score decreased in the pancreas of anti-CD25 antibody plus poly I:C-injected pregnant NOD mice.
Conclusions: We describe the use of anti-CD25 antibody to reduce regulatory T cells and poly I:C as a Toll-like receptor 3 stimulator to mimic viral infection in a pregnant NOD mouse, which can be used as a model of 'pregnancy-related' type 1 diabetes.
Keywords: NOD mouse; Pregnancy; Type 1 diabetes.
© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Figures



References
-
- Shimizu I, Makino H, Osawa H, et al. Association of fulminant type 1 diabetes with pregnancy. Diabetes Res Clin Pract 2003; 62: 33–38. - PubMed
-
- Tada A, Shimada A, Yamada T, et al. A mimic of viral double‐stranded RNA triggers fulminant type 1 diabetes‐like syndrome in regulatory T cell‐deficient autoimmune diabetic mouse. J Immunol 2011; 187: 4947–4953. - PubMed
-
- Fukushima K, Abiru N, Nagayama Y, et al. Combined insulin B:9‐23 self‐peptide and polyinosinic‐polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non‐obese diabetic mice. Biochem Biophys Res Commun 2008; 367: 719–724. - PubMed
-
- Oikawa Y, Shimada A, Kasuga A, et al. Systemic administration of IL‐18 promotes diabetes development in young nonobese diabetic mice. J Immunol 2003; 171: 5865–5875. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical